Clinical trials
Phase 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 2 |
| 2007 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 6 |
| German High-Grade Non-Hodgkin's Lymphoma Study Group | 2 |
| Amgen | 1 |
| Bristol-Myers Squibb | 1 |
| Charite University, Berlin, Germany | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Gilead Sciences | 1 |
| Martin Schrappe | 1 |
| University Hospital Muenster | 1 |
| University Hospital Schleswig-Holstein | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 16 |
| Burkitt Lymphoma | 6 |
| Lymphoma | 4 |
| Lymphoma, Follicular | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, Mantle-Cell | 4 |
| Leukemia | 3 |
| Lymphoma, B-Cell, Marginal Zone | 3 |
| Lymphoma, Large-Cell, Immunoblastic | 3 |
| Lymphoma, Non-Hodgkin | 3 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.